Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengnan Ren

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry|September 12, 2021
Benzothiophene derivatives as selective estrogen receptor covalent antagonists: Design, synthesis and anti-ERα activitiesChengfeng Bai, Shuangjie Wu, Shengnan Ren, et al.
Animal Nutrition (Zhongguo Xu Mu Shou Yi Xue Hui)|September 1, 2021
Dietary N-carbamylglutamate or l-arginine supplementation improves hepatic energy status and mitochondrial function and inhibits the AMP-activated protein kinase-peroxisome proliferator-activated receptor γ coactivator-1α-transcription factor A pathway in intrauterine-growth-retarded suckling lambsHao Zhang, Xiaoyun Liu, Shengnan Ren, et al.
Cancer Cell International|October 27, 2024
The development of the occurrence and metastasis of breast cancer by single-cell sequencingMan Chen, Mengya Feng, Hai Lei, et al.
Oncology Letters|April 29, 2016
Re-sensitization of radiation resistant colorectal cancer cells to radiation through inhibition of AMPK pathwayHongyong Jin, Sujie Gao, Huiling Guo, et al.
Molecular Therapy. Nucleic Acids|December 17, 2019
Long Noncoding RNA LINC01116 Contributes to Gefitinib Resistance in Non-small Cell Lung Cancer through Regulating IFI44He Wang, Binbin Lu, Shengnan Ren, et al.
European Journal of Medicinal Chemistry|October 5, 2021
Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancerGuoshun Luo, Xin Lin, Shengnan Ren, et al.
International Journal of Oncology|May 5, 2023
Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)Shengnan Ren, Zhanyi Zhang, Mengyuan Li, et al.
Translational Cancer Research|February 4, 2022
The expression, function, and utilization of Protamine1: a literature reviewShengnan Ren, Xuebo Chen, Xiaofeng Tian, et al.
Oncology Letters|February 20, 2016
Overexpression of ErbB2 renders breast cancer cells susceptible to 3-BrPA through the increased dissociation of hexokinase II from mitochondrial outer membraneSujie Gao, Xuebo Chen, Hongyong Jin, et al.
Surgery Open Science|May 19, 2025
Prognostic factors analysis and nomogram construction of breast cancer patients lung metastases and bone metastasesMengya Feng, Yihua Kang, Sijia Li, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|September 12, 2021
Benzothiophene derivatives as selective estrogen receptor covalent antagonists: Design, synthesis and anti-ERα activitiesChengfeng Bai, Shuangjie Wu, Shengnan Ren, et al.
Animal Nutrition (Zhongguo Xu Mu Shou Yi Xue Hui)|September 1, 2021
Dietary N-carbamylglutamate or l-arginine supplementation improves hepatic energy status and mitochondrial function and inhibits the AMP-activated protein kinase-peroxisome proliferator-activated receptor γ coactivator-1α-transcription factor A pathway in intrauterine-growth-retarded suckling lambsHao Zhang, Xiaoyun Liu, Shengnan Ren, et al.
Cancer Cell International|October 27, 2024
The development of the occurrence and metastasis of breast cancer by single-cell sequencingMan Chen, Mengya Feng, Hai Lei, et al.
Oncology Letters|April 29, 2016
Re-sensitization of radiation resistant colorectal cancer cells to radiation through inhibition of AMPK pathwayHongyong Jin, Sujie Gao, Huiling Guo, et al.
Molecular Therapy. Nucleic Acids|December 17, 2019
Long Noncoding RNA LINC01116 Contributes to Gefitinib Resistance in Non-small Cell Lung Cancer through Regulating IFI44He Wang, Binbin Lu, Shengnan Ren, et al.
European Journal of Medicinal Chemistry|October 5, 2021
Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancerGuoshun Luo, Xin Lin, Shengnan Ren, et al.
International Journal of Oncology|May 5, 2023
Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)Shengnan Ren, Zhanyi Zhang, Mengyuan Li, et al.
Translational Cancer Research|February 4, 2022
The expression, function, and utilization of Protamine1: a literature reviewShengnan Ren, Xuebo Chen, Xiaofeng Tian, et al.
Oncology Letters|February 20, 2016
Overexpression of ErbB2 renders breast cancer cells susceptible to 3-BrPA through the increased dissociation of hexokinase II from mitochondrial outer membraneSujie Gao, Xuebo Chen, Hongyong Jin, et al.
Surgery Open Science|May 19, 2025
Prognostic factors analysis and nomogram construction of breast cancer patients lung metastases and bone metastasesMengya Feng, Yihua Kang, Sijia Li, et al.
Pageof 5